Trial intelligence / Profile preview

Midazolam vs. Midazolam/Ketamine for Sedation in Phacoemulsification

NCT03054103Phase 4Completed

Sponsor
Wake Forest University Health Sciences
Start
May 2016
Primary completion
Nov 2016
01

Overview

A Phase 4 trial of ketamine in cataract, sponsored by Wake Forest University Health Sciences. Started May 2016; status: completed.

02

Drugs

ketamine
03

Conditions

cataract

Beyond the preview

Go deeper on NCT03054103.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03054103.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call